These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22568909)

  • 21. Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics.
    Vessillier S; Adams G; Montero-Melendez T; Jones R; Seed M; Perretti M; Chernajovsky Y
    Ann Rheum Dis; 2012 Jan; 71(1):143-9. PubMed ID: 21998117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and in situ hybridization of rabbit decorin in corneal tissues.
    Zhan Q; Burrows R; Cintron C
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):206-15. PubMed ID: 7822148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.
    Card KF; Price-Schiavi SA; Liu B; Thomson E; Nieves E; Belmont H; Builes J; Jiao JA; Hernandez J; Weidanz J; Sherman L; Francis JL; Amirkhosravi A; Wong HC
    Cancer Immunol Immunother; 2004 Apr; 53(4):345-57. PubMed ID: 14610621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.
    Reich N; Tomcik M; Zerr P; Lang V; Dees C; Avouac J; Palumbo K; Horn A; Akhmetshina A; Beyer C; Xie W; Bennett BL; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2012 May; 71(5):737-45. PubMed ID: 22258492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular changes in the vasculature of injured tissues.
    Järvinen TA; Ruoslahti E
    Am J Pathol; 2007 Aug; 171(2):702-11. PubMed ID: 17600129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo.
    Kim D; Jeon C; Kim JH; Kim MS; Yoon CH; Choi IS; Kim SH; Bae YS
    Exp Cell Res; 2006 May; 312(8):1277-88. PubMed ID: 16466653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
    Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
    J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.
    Curnis F; Sacchi A; Corti A
    J Clin Invest; 2002 Aug; 110(4):475-82. PubMed ID: 12189241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular targeting with phage peptide libraries.
    Pasqualini R
    Q J Nucl Med; 1999 Jun; 43(2):159-62. PubMed ID: 10429511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel peptide isolated from phage display peptides library recognized by an antibody against connective tissue growth factor (CTGF).
    Liu N; Wu G; Li H; Li L; Xing H; Zhang C; Lu H
    Int Immunopharmacol; 2009 Mar; 9(3):291-7. PubMed ID: 19103307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique.
    Yoo MK; Kang SK; Choi JH; Park IK; Na HS; Lee HC; Kim EB; Lee NK; Nah JW; Choi YJ; Cho CS
    Biomaterials; 2010 Oct; 31(30):7738-47. PubMed ID: 20656343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
    Yang VC; Naik SS; Song H; Dombkowski AA; Crippen G; Liang JF
    J Control Release; 2005 Dec; 110(1):164-76. PubMed ID: 16260060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells.
    Sacco E; Metalli D; Spinelli M; Manzoni R; Samalikova M; Grandori R; Morrione A; Traversa S; Alberghina L; Vanoni M
    Biotechnol Adv; 2012; 30(1):233-43. PubMed ID: 21620943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric VEGF-ENZ7/PlGF specifically binding to VEGFR-2 accelerates skin wound healing via enhancement of neovascularization.
    Zheng Y; Watanabe M; Kuraishi T; Hattori S; Kai C; Shibuya M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):503-11. PubMed ID: 17194893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
    Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
    Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.